Trisura Group (TSU.TO) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Trisura Group (TSU.TO)

42.54

+0.22 (0.52%)

as of Aug 13, 2026, 6:21:45 pm Market Open.

101 watching

Investor Insights

Aug 13, 2026, 12:00 am

This summary was created by AI, based on 5 opinions in the last 12 months.

Trisura Group (TSU) has been facing challenges due to asset impairments and a volatile insurance market, yet it continues to exhibit strong underlying business fundamentals. The company holds a significant presence in Canada and is aggressively expanding into the U.S. market, particularly in the surety and specialty insurance sectors. Analysts note the potential for robust earnings growth and an attractive return on equity, despite its stock trading sideways for several years. Additionally, TSU's solid cash position makes it a potential acquisition target, and expert opinions highlight its favorable valuation metrics compared to its peers. Overall, while the stock may seem under pressure, there is optimism regarding its future growth prospects.

Consensus

Hold

Valuation

Undervalued

Similar

IFC

BUY

Stable P&C business growing nicely in Canada. Cashflow from that is funding a US surety and specialty insurance business, which is wildly profitable and growing fast. Smart CEO. Good growth, high ROE, lots of optionality.

Premium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

TOP PICK

Stockchase Research Editor: Michael O'Reilly We reiterate TSU, a specialty insurance company focusing on surety bonds, corporate and fee based insurance services as a TOP PICK. The company recently acquired another Canadian surety business, which will be accretive to earnings. We recommend trailing up the stop (from $26) to $31, looking to achieve $56 -- upside potential over 45%. Yield 0% (Analysts’ price target is $56.29)

BUY

Insurer that operates in Canada and US. Great business. Growing rapidly, which generates more capital. Strong quarters, with one hiccup. Once the market stabilizes, he sees stock at $40+. Add at these levels.

Premium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

TOP PICK

Stockchase Research Editor: Michael O'Reilly This specialty insurance company, focusing on surety bonds, corporate and fee based insurance services, recently reported earnings 30% above analyst expectations and a ROE over 27%. It has a conservative balance sheet supported by an investment grade rating. Expectations are that next years earnings will be another 50% higher. Forward PE is projected at 16x earnings. We recommend setting a stop loss at $26, looking to achieve $46 -- upside potential over 30%. Yield 0% (Analysts’ price target is $56.00)

PAST TOP PICK

(A Top Pick Jun 09/21, Up 3%) Would buy shares in the company again & continues to hold. Very impressed with management team and return on equity metrics. Company has recently raised $150 MM. Very good quarter with earnings and performance.

BUY

Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. A relatively small insurance company that has good growth and market share gains. Playing in a fragmented market and they could acquire more companies. Better upside than larger insurers like Sunlife and Manulife. Unlock Premium - Try 5i Free

BUY ON WEAKNESS

An insurance company. Cashflow has been through their PnC insurance business in Canada. This has funded the specialty insurance in the US. A spin-off of BAM.A. A fantastic company that is growing 50%+ and it is expected to continue with a mix of organic and acquisitions.

BUY

Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. The company reported strong earnings results. EPS beat estimates at $0.38 and revenues were $404.68M. Revenues also grew by 68.9% yoy. Very strong results that should make investors happy. The company is cheap relative to results. Unlock Premium - Try 5i Free

BUY

Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. TSU reported an EPS of $0.35 that beat expectations by 6 cents. Gross premiums written had good growth and ROE for the quarter was strong at 18.3%. Unlock Premium - Try 5i Free

TOP PICK

Specialty insurance. Spun out of one of the Brookfields. US business, called fronting, is very exciting, and it crosses state lines. Growth profile is fantastic. High and growing ROEs, growing access to capital, dynamic CEO. No dividend. (Analysts’ price target is $178.13)

TOP PICK

A spin-off of Brookfield Asset Management. For every 170 shares of BAM-T one owned, they received one share of TSU-T. They underwrite smaller BTB insurance. They can sell-off re-insurance for a recurring fee stream in the US – a process called “fronting”. On paper it looks like they operate at a loss, but it will be prove up in time. Yield 0%. (Analysts’ price target is $32.00)

Showing 31 to 41 of 41 entries

Most Recent Experts

Stan Wong

Private Wealth Management, ScotiaMcleod

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Chris Blumas

at Raymond James Investment Counsel Ltd.

Shannon Saccocia, CIO, Boston Private

Boston Private

Wealthica The ultimate 360° Tracker Your financial life in one place, automatically

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Trisura Group (TSU.TO)